Childhood Cancer

You are here

Home » Grants » All grants tagged with "Rhabdomyosarcoma"

All grants tagged with "Rhabdomyosarcoma"

Pathological Condensates and Transcription Dysregulation in Rhabdomyosarcoma at Single-Molecule Resolution
Shasha Chong, PhD
California Institute of Technology
Innovation Grants, Awarded 2024
Improving homing and activity of CAR T cells in pediatric sarcomas
Joselyn Cruz Cruz, PhD
University of Colorado Denver
Young Investigator Grants, Awarded 2024
Novel mechanisms and therapeutic targeting of chemoresistant rhabdomyosarcoma
Yueyang Wang, PhD
Massachusetts General Hospital
Young Investigator Grants, Awarded 2024
Targeting chromatin remodeling complex controlled fusion protein function in rhabdosarcoma
Sunwoo Lee
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2024
Investigating oncogenic drivers of therapy resistance and cell states in rhabdomyosarcoma
Ilyas Oultache
Massachusetts General Hospital
POST Program Grants, Awarded 2024
Combined BET and mTORC inhibition in fusion positive rhabdomyosarcoma
Rishika Mehta
University of California San Francisco
POST Program Grants, Awarded 2024
Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors
Andras Heczey, MD
Baylor College of Medicine
R Accelerated Award Grants, Awarded 2023
Development of New Approaches to Target MAP Kinase Pathway in RAS-driven Rhabdomyosarcoma
Angelina Vaseva, PhD
University of Texas Health Science Center at San Antonio
R Accelerated Award Grants, Awarded 2023
Unraveling the Function of PAX3-FOXO1’s Activation Domain in Rhabdomyosarcoma
Berkley Gryder, PhD
Case Western Reserve University
'A' Award Grants, Awarded 2023
Genomic and nuclear organizational changes in chemotherapy-resistant rhabdomyosarcoma cells
Kyle MacQuarrie, MD/PhD
Ann & Robert H. Lurie Children’s Hospital of Chicago
'A' Award Grants, Awarded 2023

Pages

All childhood cancer types

Featured Hero

Ailani Myers

Ailani's family calls her a true Warrior Princess as she fights acute lymphoblastic leukemia. Doctors discovered Ailani harbored a rare genetic mutation which makes standard treatment ineffective. Today, Ailani has reached remission!
Read more »